After 18 years of living with multiple myeloma, Sally Kalksma has learned that getting through cancer treatment is about more ...
Researchers are studying whether combining CAR-T cell therapy with targeted drugs could help children with high-risk leukemia ...
In the latest installment of CURE's "Text a Survivor" series, Brad Moore answers some of the most common questions people have about living with and beyond a colorectal cancer diagnosis.
Researchers are studying whether combining CAR-T cell therapy with targeted drugs could help children with high-risk leukemia, including infants whose cancer may be more likely to return after ...
The omnipresence of pink during awareness campaigns can function as an involuntary cue for trauma recall, reactivating ...
A partially randomized patient-preference design showed intervention receipt, not preference congruence, drove improvements in fatigue, sleep, and pain interference among distressed post-treatment ...
Progression-free survival reached 14.3 months with Enhertu versus 8.3 months with chemotherapy plus Keytruda in HER2-mutant lung cancer. In the phase 3 DESTINY-Lung04 trial, patients with HER2-mutant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results